<!DOCTYPE html>
<html lang="de">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Fetts√§ure-Oxidationsst√∂rungen - Teil 3</title>
    <style>
        body {
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
            margin: 0;
            padding: 0;
            background-color: #f8f9fa;
            line-height: 1.6;
        }
        
        .container {
            max-width: 1000px;
            margin: 0 auto;
            background: white;
            box-shadow: 0 0 20px rgba(0,0,0,0.1);
        }
        
        .header {
            background: linear-gradient(135deg, #8e44ad, #e74c3c, #f39c12);
            color: white;
            padding: 40px 30px;
            text-align: center;
            position: relative;
        }
        
        .header::before {
            content: "üíä";
            font-size: 3rem;
            display: block;
            margin-bottom: 10px;
        }
        
        .header h1 {
            margin: 0;
            font-size: 2.5rem;
            font-weight: 300;
        }
        
        .header .subtitle {
            font-size: 1.1rem;
            margin-top: 10px;
            opacity: 0.9;
        }
        
        .progress-bar {
            height: 4px;
            background: linear-gradient(90deg, #8e44ad, #e74c3c, #f39c12);
            width: 100%;
        }
        
        .info-box {
            background: linear-gradient(135deg, #e3f2fd, #bbdefb);
            margin: 20px;
            padding: 20px;
            border-radius: 8px;
            border-left: 4px solid #2196f3;
        }
        
        .info-box .icon {
            display: inline-block;
            margin-right: 10px;
            font-size: 1.2rem;
        }
        
        .navigation {
            display: flex;
            flex-wrap: wrap;
            gap: 10px;
            padding: 20px;
            background: #f5f5f5;
        }
        
        .nav-item {
            background: linear-gradient(135deg, #6c757d, #495057);
            color: white;
            padding: 12px 20px;
            border-radius: 25px;
            text-decoration: none;
            font-weight: 500;
            transition: all 0.3s ease;
            border: none;
            cursor: pointer;
        }
        
        .nav-item.active {
            background: linear-gradient(135deg, #e91e63, #ad1457);
        }
        
        .nav-item:hover {
            transform: translateY(-2px);
            box-shadow: 0 5px 15px rgba(0,0,0,0.2);
        }
        
        .content {
            padding: 30px;
        }
        
        .section-header {
            display: flex;
            align-items: center;
            margin-bottom: 30px;
        }
        
        .section-header::before {
            content: "‚ö°";
            font-size: 2rem;
            margin-right: 15px;
        }
        
        .section-header h2 {
            color: #8e44ad;
            margin: 0;
            font-size: 1.8rem;
        }
        
        .therapy-container {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(400px, 1fr));
            gap: 20px;
            margin: 20px 0;
        }
        
        .therapy-box {
            background: linear-gradient(135deg, #e8f5e8, #c8e6c9);
            padding: 25px;
            border-radius: 12px;
            border: 2px solid #4caf50;
        }
        
        .therapy-box h3 {
            color: #2e7d32;
            margin-top: 0;
            display: flex;
            align-items: center;
        }
        
        .therapy-box.dietary h3::before { content: "ü•ó"; margin-right: 10px; }
        .therapy-box.medication h3::before { content: "üíä"; margin-right: 10px; }
        .therapy-box.supplement h3::before { content: "üß™"; margin-right: 10px; }
        
        .dosage-table {
            width: 100%;
            border-collapse: collapse;
            margin: 15px 0;
            font-size: 0.9rem;
        }
        
        .dosage-table th {
            background: #2e7d32;
            color: white;
            padding: 10px;
            text-align: left;
            font-weight: 600;
        }
        
        .dosage-table td {
            padding: 8px 10px;
            border-bottom: 1px solid #c8e6c9;
        }
        
        .emergency-protocol {
            background: linear-gradient(135deg, #ffebee, #ffcdd2);
            padding: 25px;
            border-radius: 12px;
            margin: 20px 0;
            border: 2px solid #f44336;
        }
        
        .emergency-protocol h3 {
            color: #c62828;
            margin-top: 0;
            display: flex;
            align-items: center;
            font-size: 1.5rem;
        }
        
        .emergency-protocol h3::before {
            content: "üö®";
            margin-right: 10px;
        }
        
        .emergency-step {
            background: white;
            padding: 15px;
            margin: 15px 0;
            border-radius: 8px;
            border-left: 4px solid #f44336;
            position: relative;
        }
        
        .emergency-step.immediate {
            border-left-color: #f44336;
            background: #ffebee;
        }
        
        .emergency-step.urgent {
            border-left-color: #ff9800;
            background: #fff3e0;
        }
        
        .emergency-step.monitoring {
            border-left-color: #2196f3;
            background: #e3f2fd;
        }
        
        .emergency-step::before {
            content: counter(step-counter);
            counter-increment: step-counter;
            position: absolute;
            left: -15px;
            top: 10px;
            background: #f44336;
            color: white;
            width: 25px;
            height: 25px;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-weight: bold;
            font-size: 0.8rem;
        }
        
        .emergency-protocol {
            counter-reset: step-counter;
        }
        
        .quick-reference {
            background: linear-gradient(135deg, #fff8e1, #ffecb3);
            padding: 25px;
            border-radius: 12px;
            margin: 20px 0;
            border: 2px solid #ffc107;
        }
        
        .quick-reference h3 {
            color: #f57f17;
            margin-top: 0;
            display: flex;
            align-items: center;
        }
        
        .quick-reference h3::before {
            content: "‚ö°";
            margin-right: 10px;
        }
        
        .drug-table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            box-shadow: 0 2px 10px rgba(0,0,0,0.1);
            border-radius: 8px;
            overflow: hidden;
        }
        
        .drug-table th {
            background: linear-gradient(135deg, #8e44ad, #9b59b6);
            color: white;
            padding: 15px;
            text-align: left;
            font-weight: 600;
        }
        
        .drug-table td {
            padding: 12px 15px;
            border-bottom: 1px solid #eee;
        }
        
        .drug-table tr:nth-child(even) {
            background: #f8f9fa;
        }
        
        .drug-table tr:hover {
            background: #e3f2fd;
        }
        
        .monitoring-box {
            background: linear-gradient(135deg, #f3e5f5, #e1bee7);
            padding: 25px;
            border-radius: 12px;
            margin: 20px 0;
            border: 2px solid #9c27b0;
        }
        
        .monitoring-box h3 {
            color: #6a1b9a;
            margin-top: 0;
            display: flex;
            align-items: center;
        }
        
        .monitoring-box h3::before {
            content: "üìä";
            margin-right: 10px;
        }
        
        .monitoring-schedule {
            background: white;
            padding: 15px;
            margin: 15px 0;
            border-radius: 8px;
            border-left: 4px solid #9c27b0;
        }
        
        .prognosis-box {
            background: linear-gradient(135deg, #e0f2f1, #b2dfdb);
            padding: 25px;
            border-radius: 12px;
            margin: 20px 0;
            border: 2px solid #009688;
        }
        
        .prognosis-box h3 {
            color: #00695c;
            margin-top: 0;
            display: flex;
            align-items: center;
        }
        
        .prognosis-box h3::before {
            content: "üéØ";
            margin-right: 10px;
        }
        
        .patient-card {
            background: linear-gradient(135deg, #fff3e0, #ffe0b2);
            padding: 25px;
            border-radius: 12px;
            margin: 20px 0;
            border: 2px solid #ff9800;
        }
        
        .patient-card h3 {
            color: #ef6c00;
            margin-top: 0;
            display: flex;
            align-items: center;
        }
        
        .patient-card h3::before {
            content: "üÜî";
            margin-right: 10px;
        }
        
        .emergency-card {
            background: white;
            border: 2px solid #f44336;
            border-radius: 8px;
            padding: 20px;
            margin: 15px 0;
            box-shadow: 0 4px 8px rgba(0,0,0,0.1);
        }
        
        .emergency-card h4 {
            color: #c62828;
            margin-top: 0;
            text-align: center;
            font-size: 1.1rem;
        }
        
        .emergency-contacts {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
            gap: 10px;
            margin: 15px 0;
        }
        
        .contact-item {
            background: #ffebee;
            padding: 10px;
            border-radius: 5px;
            text-align: center;
        }
        
        .warning-highlight {
            background: linear-gradient(135deg, #ffebee, #ffcdd2);
            padding: 15px;
            border-radius: 8px;
            margin: 15px 0;
            border-left: 4px solid #f44336;
        }
        
        .warning-highlight::before {
            content: "‚ö†Ô∏è";
            margin-right: 10px;
            font-size: 1.2rem;
        }
        
        .success-highlight {
            background: linear-gradient(135deg, #e8f5e8, #c8e6c9);
            padding: 15px;
            border-radius: 8px;
            margin: 15px 0;
            border-left: 4px solid #4caf50;
        }
        
        .success-highlight::before {
            content: "‚úÖ";
            margin-right: 10px;
            font-size: 1.2rem;
        }
        
        .completion-box {
            background: linear-gradient(135deg, #8e44ad, #9b59b6);
            color: white;
            padding: 25px;
            border-radius: 12px;
            text-align: center;
            margin-top: 40px;
        }
        
        .completion-box h3 {
            margin: 0 0 15px 0;
            font-size: 1.5rem;
        }
        
        .completion-box::before {
            content: "üéì";
            font-size: 3rem;
            display: block;
            margin-bottom: 15px;
        }
        
        @media (max-width: 768px) {
            .header {
                padding: 30px 20px;
            }
            
            .header h1 {
                font-size: 2rem;
            }
            
            .content {
                padding: 20px;
            }
            
            .navigation {
                flex-direction: column;
            }
            
            .therapy-container {
                grid-template-columns: 1fr;
            }
            
            .drug-table, .dosage-table {
                font-size: 0.8rem;
            }
            
            .emergency-contacts {
                grid-template-columns: 1fr;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <header class="header">
            <h1>Fetts√§ure-Oxidationsst√∂rungen</h1>
            <div class="subtitle">Teil 3: Therapie & Notfallmanagement</div>
        </header>
        
        <div class="progress-bar"></div>
        
        <div class="info-box">
            <span class="icon">‚ö°</span>
            <strong>Lerneinheit Teil 3</strong><br>
            Dieser finale Teil behandelt die therapeutischen Strategien, Notfall-Protokolle und Langzeitbetreuung mit konkreten Handlungsanweisungen f√ºr die klinische Praxis.
        </div>
        
        <nav class="navigation">
            <button class="nav-item" onclick="alert('Teil 1: Grundlagen & Pathophysiologie')">1. GRUNDLAGEN</button>
            <button class="nav-item" onclick="alert('Teil 2: Klinische Pr√§sentation & Diagnostik')">2. KLINISCHE PR√ÑSENTATION</button>
            <button class="nav-item" onclick="alert('Teil 2: Klinische Pr√§sentation & Diagnostik')">3. DIAGNOSTIK</button>
            <button class="nav-item active">4. THERAPIE</button>
            <button class="nav-item active">5. NOTFALLMANAGEMENT</button>
        </nav>
        
        <main class="content">
            <div class="section-header">
                <h2>Therapeutische Strategien</h2>
            </div>
            
            <div class="therapy-container">
                <div class="therapy-box dietary">
                    <h3>Di√§tetische Therapie</h3>
                    
                    <h4>Grundprinzipien:</h4>
                    <ul>
                        <li><strong>Vermeidung prolongierter Fastenzeiten</strong></li>
                        <li><strong>Regelm√§√üige Kohlenhydratzufuhr</strong></li>
                        <li><strong>Fettreduktion bei LCAD/VLCAD</strong></li>
                        <li><strong>MCT-√ñl als Energiequelle</strong></li>
                    </ul>
                    
                    <h4>Altersabh√§ngige Fastenzeiten:</h4>
                    <table class="dosage-table">
                        <thead>
                            <tr>
                                <th>Alter</th>
                                <th>Max. Fastenzeit</th>
                                <th>Nachtmahlzeit</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td>0-6 Monate</td>
                                <td>3-4 Stunden</td>
                                <td>Alle 3h</td>
                            </tr>
                            <tr>
                                <td>6-12 Monate</td>
                                <td>6-8 Stunden</td>
                                <td>Sp√§te Abendmahlzeit</td>
                            </tr>
                            <tr>
                                <td>1-2 Jahre</td>
                                <td>8-10 Stunden</td>
                                <td>Sp√§tmahlzeit + fr√ºh Fr√ºhst√ºck</td>
                            </tr>
                            <tr>
                                <td>>2 Jahre</td>
                                <td>10-12 Stunden</td>
                                <td>Kohlenhydratreiche Sp√§tmahlzeit</td>
                            </tr>
                        </tbody>
                    </table>
                </div>
                
                <div class="therapy-box medication">
                    <h3>Medikament√∂se Therapie</h3>
                    
                    <h4>L-Carnitin (Carnitor¬Æ):</h4>
                    <table class="dosage-table">
                        <thead>
                            <tr>
                                <th>Indikation</th>
                                <th>Dosierung</th>
                                <th>Bemerkung</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td>Prim√§rer Carnitin-Mangel</td>
                                <td>100-200 mg/kg/Tag</td>
                                <td>Lebensrettend</td>
                            </tr>
                            <tr>
                                <td>VLCAD, LCHAD</td>
                                <td>50-100 mg/kg/Tag</td>
                                <td>Symptomatisch</td>
                            </tr>
                            <tr>
                                <td>MCAD</td>
                                <td>50 mg/kg/Tag</td>
                                <td>Umstritten</td>
                            </tr>
                        </tbody>
                    </table>
                    
                    <h4>MCT-√ñl (C8-C10 Fetts√§uren):</h4>
                    <ul>
                        <li><strong>VLCAD/LCHAD:</strong> 1-2 g/kg/Tag</li>
                        <li><strong>Einschleichend:</strong> 0,25 g/kg/Tag steigern</li>
                        <li><strong>Nebenwirkungen:</strong> Diarrh√∂, Bauchkr√§mpfe</li>
                    </ul>
                </div>
            </div>
            
            <h3>Erkrankungsspezifische Therapie</h3>
            
            <table class="drug-table">
                <thead>
                    <tr>
                        <th>Erkrankung</th>
                        <th>Di√§t</th>
                        <th>L-Carnitin</th>
                        <th>MCT-√ñl</th>
                        <th>Besonderheiten</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>MCAD-Mangel</strong></td>
                        <td>Normale Kost<br>Fastenzeiten ‚Üì</td>
                        <td>Umstritten<br>50 mg/kg/Tag</td>
                        <td>Nicht erforderlich</td>
                        <td>Glucagon-Notfallset</td>
                    </tr>
                    <tr>
                        <td><strong>VLCAD-Mangel</strong></td>
                        <td>Fettarm (<20% kcal)<br>LCT ‚Üì</td>
                        <td>50-100 mg/kg/Tag</td>
                        <td>1-2 g/kg/Tag</td>
                        <td>Kardiomyopathie-Monitoring</td>
                    </tr>
                    <tr>
                        <td><strong>LCHAD/TFP-Mangel</strong></td>
                        <td>Sehr fettarm (<10%)<br>LCT strikt ‚Üì</td>
                        <td>100 mg/kg/Tag</td>
                        <td>2-3 g/kg/Tag</td>
                        <td>DHA-Substitution<br>Retina-Kontrollen</td>
                    </tr>
                    <tr>
                        <td><strong>CPT I-Mangel</strong></td>
                        <td>Fettarm<br>MCT bevorzugt</td>
                        <td>Kontraindiziert!</td>
                        <td>2-3 g/kg/Tag</td>
                        <td>L-Carnitin verschlechtert!</td>
                    </tr>
                    <tr>
                        <td><strong>CPT II-Mangel</strong></td>
                        <td>Fettarm bei Myopathie<br>Sport-Einschr√§nkung</td>
                        <td>50-100 mg/kg/Tag</td>
                        <td>1-2 g/kg/Tag</td>
                        <td>Bezafibrat bei Erwachsenen</td>
                    </tr>
                    <tr>
                        <td><strong>Prim√§rer Carnitin-Mangel</strong></td>
                        <td>Normale Kost</td>
                        <td>100-200 mg/kg/Tag</td>
                        <td>Nicht erforderlich</td>
                        <td>Lebenslange Therapie<br>Familienscreening</td>
                    </tr>
                </tbody>
            </table>
            
            <div class="section-header">
                <h2>üö® Notfallmanagement</h2>
            </div>
            
            <div class="emergency-protocol">
                <h3>Akut-Protokoll bei metabolischer Krise</h3>
                
                <div class="emergency-step immediate">
                    <h4>Sofortma√ünahmen (0-15 min)</h4>
                    <ul>
                        <li><strong>Ven√∂ser Zugang:</strong> Gro√ülumig (mind. 20G)</li>
                        <li><strong>Glukose 10%:</strong> 2-4 ml/kg i.v. als Bolus</li>
                        <li><strong>Dauertropf:</strong> Glukose 10% mit 6-8 mg/kg/min</li>
                        <li><strong>Laborabnahme:</strong> BZ, BGA, Elektrolyte, Ammoniak, Laktat</li>
                        <li><strong>Monitoring:</strong> Kontinuierliche BZ-Kontrolle</li>
                    </ul>
                </div>
                
                <div class="emergency-step urgent">
                    <h4>Erweiterte Ma√ünahmen (15-60 min)</h4>
                    <ul>
                        <li><strong>Bei BZ <50 mg/dl:</strong> Glukose 20% 1-2 ml/kg</li>
                        <li><strong>Bei Hyperammon√§mie >150 Œºmol/L:</strong> Ammoniaksenkung einleiten</li>
                        <li><strong>L-Carnitin:</strong> 100 mg/kg i.v. (au√üer CPT I-Mangel!)</li>
                        <li><strong>Azidosekorrektur:</strong> NaHCO‚ÇÉ nur bei pH <7,1</li>
                        <li><strong>Speziallabor:</strong> Acylcarnitine, org. S√§uren</li>
                    </ul>
                </div>
                
                <div class="emergency-step monitoring">
                    <h4>Stabilisierung und Monitoring (1-24h)</h4>
                    <ul>
                        <li><strong>BZ-Ziel:</strong> 80-120 mg/dl (4,4-6,7 mmol/L)</li>
                        <li><strong>Glukose-Rate:</strong> Schrittweise auf 4-6 mg/kg/min reduzieren</li>
                        <li><strong>Orale Nahrung:</strong> Nach Stabilisierung langsam aufbauen</li>
                        <li><strong>Kontrollparameter:</strong> BZ 2-st√ºndlich, BGA, Elektrolyte</li>
                        <li><strong>Intensivstation:</strong> Bei Bewusstseinsst√∂rung oder instabiler H√§modynamik</li>
                    </ul>
                </div>
            </div>
            
            <div class="quick-reference">
                <h3>Notfall-Medikamente: Dosierungen</h3>
                
                <div style="display: grid; grid-template-columns: repeat(auto-fit, minmax(250px, 1fr)); gap: 15px;">
                    <div style="background: white; padding: 15px; border-radius: 8px;">
                        <h4>üçØ Glukose 10%</h4>
                        <p><strong>Bolus:</strong> 2-4 ml/kg i.v.<br>
                        <strong>Dauertropf:</strong> 6-8 mg/kg/min<br>
                        <strong>Ziel-BZ:</strong> 80-120 mg/dl</p>
                    </div>
                    
                    <div style="background: white; padding: 15px; border-radius: 8px;">
                        <h4>üíä L-Carnitin</h4>
                        <p><strong>Akut:</strong> 100 mg/kg i.v.<br>
                        <strong>Oral:</strong> 50-200 mg/kg/Tag<br>
                        <strong>Kontraindikation:</strong> CPT I-Mangel</p>
                    </div>
                    
                    <div style="background: white; padding: 15px; border-radius: 8px;">
                        <h4>üß™ Notfall-Labor</h4>
                        <p><strong>Sofort:</strong> BZ, BGA, Elektrolyte<br>
                        <strong>Innerhalb 1h:</strong> Ammoniak, Laktat<br>
                        <strong>Speziallabor:</strong> Acylcarnitine, org. S√§uren</p>
                    </div>
                    
                    <div style="background: white; padding: 15px; border-radius: 8px;">
                        <h4>‚ö†Ô∏è Hyperammon√§mie</h4>
                        <p><strong>Ab 150 Œºmol/L:</strong> Ammoniaksenkung<br>
                        <strong>Arginin:</strong> 250 mg/kg i.v.<br>
                        <strong>Benzoat:</strong> 250 mg/kg i.v.</p>
                    </div>
                </div>
            </div>
            
            <div class="warning-highlight">
                <strong>Kritische Punkte:</strong> Bei CPT I-Mangel ist L-Carnitin kontraindiziert und kann zu Verschlechterung f√ºhren! Immer Diagnose verifizieren vor Carnitin-Gabe.
            </div>
            
            <div class="patient-card">
                <h3>Notfall-Ausweis f√ºr Patienten</h3>
                
                <div class="emergency-card">
                    <h4>üÜî NOTFALL-AUSWEIS</h4>
                    <h4>Fetts√§ure-Oxidationsst√∂rung</h4>
                    
                    <div style="text-align: left; margin: 15px 0;">
                        <p><strong>Patient:</strong> ________________________________</p>
                        <p><strong>Geburtsdatum:</strong> ___________________________</p>
                        <p><strong>Diagnose:</strong> _________________________________</p>
                        <p><strong>Behandelndes Zentrum:</strong> ____________________</p>
                    </div>
                    
                    <div style="background: #ffcdd2; padding: 15px; border-radius: 5px; margin: 15px 0;">
                        <h4 style="margin: 0; color: #c62828;">üö® IM NOTFALL:</h4>
                        <ul style="margin: 10px 0; text-align: left;">
                            <li>Sofort i.v. Zugang + Glukose 10%</li>
                            <li>KEIN FASTEN! Kontinuierliche Glukosezufuhr</li>
                            <li>Blutzucker >80 mg/dl halten</li>
                            <li>Bei Bewusstlosigkeit: Glukagon i.m.</li>
                        </ul>
                    </div>
                    
                    <div class="emergency-contacts">
                        <div class="contact-item">
                            <strong>Notarzt</strong><br>
                            üìû 112
                        </div>
                        <div class="contact-item">
                            <strong>Stoffwechselzentrum</strong><br>
                            üìû _______________
                        </div>
                        <div class="contact-item">
                            <strong>24h-Bereitschaft</strong><br>
                            üìû _______________
                        </div>
                    </div>
                </div>
            </div>
            
            <div class="section-header">
                <h2>üìä Langzeitbetreuung & Monitoring</h2>
            </div>
            
            <div class="monitoring-box">
                <h3>Kontrolluntersuchungen</h3>
                
                <div class="monitoring-schedule">
                    <h4>Alle 3 Monate (erste 2 Jahre):</h4>
                    <ul>
                        <li>Anthropometrie (Gewicht, L√§nge, Kopfumfang)</li>
                        <li>Entwicklungsbeurteilung</li>
                        <li>Acylcarnitin-Profil + freies Carnitin</li>
                        <li>Leberwerte (AST, ALT, GGT)</li>
                        <li>CK bei Myopathie-Risiko</li>
                    </ul>
                </div>
                
                <div class="monitoring-schedule">
                    <h4>Alle 6 Monate (ab 2 Jahren):</h4>
                    <ul>
                        <li>Wachstum und Entwicklung</li>
                        <li>Laborkontrollen (s.o.)</li>
                        <li>Echokardiographie (bei VLCAD, LCHAD)</li>
                        <li>Compliance-Check Therapie</li>
                        <li>Ern√§hrungsberatung</li>
                    </ul>
                </div>
                
                <div class="monitoring-schedule">
                    <h4>J√§hrlich:</h4>
                    <ul>
                        <li>Ophthalmologische Untersuchung (LCHAD)</li>
                        <li>Neuropsychologische Testung</li>
                        <li>Belastungs-EKG (ab Jugendlichenalter)</li>
                        <li>Knochendichte (bei Langzeit-Fettrestriktion)</li>
                        <li>Vitamin-Status (A, D, E, K)</li>
                    </ul>
                </div>
            </div>
            
            <div class="prognosis-box">
                <h3>Prognose und Komplikationen</h3>
                
                <h4>Excellent Prognose bei:</h4>
                <div class="success-highlight">
                    MCAD-Mangel mit fr√ºher Diagnose und konsequenter Prophylaxe - normale Lebenserwartung und Lebensqualit√§t
                </div>
                
                <h4>Gute Prognose bei:</h4>
                <ul>
                    <li><strong>Prim√§rer Carnitin-Mangel:</strong> Vollst√§ndige Reversibilit√§t unter Therapie</li>
                    <li><strong>VLCAD (milde Form):</strong> Normale Entwicklung bei Therapie</li>
                    <li><strong>CPT II (myopathische Form):</strong> Stabile Symptomatik</li>
                </ul>
                
                <h4>Erschwerte Prognose bei:</h4>
                <div class="warning-highlight">
                    <strong>LCHAD/TFP-Mangel:</strong> Retinopathie in 60-80%, progressive Polyneuropathie, erh√∂htes Mortalit√§tsrisiko trotz Therapie
                </div>
                
                <h4>Langzeit-Komplikationen:</h4>
                <ul>
                    <li><strong>Neurokognitive Entwicklung:</strong> Meist normal bei fr√ºher Therapie</li>
                    <li><strong>Kardiomyopathie:</strong> Reversibel bei VLCAD, persistent bei LCHAD</li>
                    <li><strong>Fettstoffwechselst√∂rung:</strong> Erh√∂htes kardiovaskul√§res Risiko</li>
                    <li><strong>Osteopenie:</strong> Bei langfristiger Fettrestriktion</li>
                </ul>
            </div>
            
            <div class="success-highlight">
                <strong>Schl√ºssel zum Erfolg:</strong> Fr√ºhe Diagnose + konsequente Prophylaxe + strukturierte Langzeitbetreuung = Excellent Outcome bei den meisten FAO-St√∂rungen
            </div>
            
            <div class="completion-box">
                <h3>Lerneinheit abgeschlossen</h3>
                <p>Sie haben erfolgreich alle drei Teile der Fetts√§ure-Oxidationsst√∂rungen durchgearbeitet und kennen nun:</p>
                <ul style="text-align: left; max-width: 600px; margin: 0 auto;">
                    <li>‚úÖ Pathophysiologie und Klassifikation</li>
                    <li>‚úÖ Klinische Pr√§sentation und Diagnostik</li>
                    <li>‚úÖ Therapeutische Strategien</li>
                    <li>‚úÖ Notfallmanagement und Langzeitbetreuung</li>
                </ul>
                <p style="margin-top: 20px;">Sie sind nun in der Lage, Patienten mit FAO-St√∂rungen kompetent zu betreuen!</p>
            </div>
        </main>
    </div>
</body>
</html>